Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Govt. Outlines Hands-Off Approach to Boosting VC

This article was originally published in The Pink Sheet Daily

Executive Summary

British government is providing £150 million ($250 million) to kick of an innovation-focused fund-of-funds in life sciences and other technology.

You may also be interested in...



Wealthy Families Play A Growing Role in European Biotech Financing

The continued dearth of venture capital in Europe is highlighting the key role played by wealthy families as an alternative – or at least complementary – source of finance for biopharmaceutical firms.

Wealthy Families Play A Growing Role in European Biotech Financing

The continued dearth of venture capital in Europe is highlighting the key role played by wealthy families as an alternative – or at least complementary – source of finance for biopharmaceutical firms.

UK Innovation Investment Fund: Are The Right Managers On The Job?

An effort to close the venture funding gap with the U.S. gets potential help in several ways.

Related Content

Topics

UsernamePublicRestriction

Register

PS068792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel